fb pixel

Grey Death: What It Was, What Replaced It, and Why Carfentanil Still Matters

Chart comparing the composition of grey death in 2017 with the fentanyl adulterants identified by the DEA in 2026.

Table of Contents

Quick Answer

Grey death was a nickname given in 2016 and 2017 to a grey, concrete-looking street opioid mixture found mostly in Georgia, Ohio, and Alabama. It was never a single drug with a fixed formula. Each seized batch contained a different combination of heroin, fentanyl, U-47700, and sometimes carfentanil. The name has largely disappeared from federal drug surveillance, but the problem it described did not disappear. It became the entire illicit opioid supply: unlabeled mixtures of unknown potency. Carfentanil, the most potent component ever identified in grey death samples, re-emerged in the U.S. drug supply and was detected in roughly seven times more overdose deaths in early 2024 than in early 2023.

Key Facts at a Glance

What it was A street name for a grey, cement-like opioid powder or chunk, not an individual drug
When it appeared Late 2016 into 2017
Where it was reported Georgia, Ohio, Alabama, Pennsylvania, Indiana, and later Louisiana
Known components Heroin, illicitly manufactured fentanyl, U-47700, furanyl fentanyl, carfentanil, in varying and unpredictable proportions
Why the name faded Forensic laboratories report the compounds detected, not street nicknames. Variable fentanyl mixtures became the norm rather than an anomaly.
What matters in 2026 Carfentanil detections rose sharply in 2024. Xylazine, medetomidine, nitazenes, and cychlorphine are now the adulterants federal agencies are warning about.
Overdose reversal Naloxone reverses opioids, including carfentanil, though more doses may be required. It does not reverse xylazine or medetomidine, which are not opioids.

What Was Grey Death?

Grey death was a name given by law enforcement and the press to a drug product that began surfacing in the southeastern United States at the end of 2016. It got the name from its appearance. Seized samples looked like dry concrete mix, sometimes a hard chunky material and sometimes a fine grey powder.

The important point, then and now, is that grey death was never a drug. It was a description of how something looked. Forensic chemists at the Georgia Bureau of Investigation analyzed dozens of samples during the first half of 2017 and found that no two batches were reliably alike. Some contained heroin. Some contained illicitly manufactured fentanyl. Some contained U-47700, a synthetic opioid sold online as a research chemical and sometimes called “pink.” Some contained furanyl fentanyl. Some contained carfentanil. The grey color itself was never fully explained, and no single ingredient accounted for it.

That inconsistency was the hazard. A person buying grey death had no way to know which opioids were in the batch, in what concentration, or how that batch compared with the last one. Two purchases that looked identical could differ in potency by orders of magnitude.

Is Grey Death Still Around in 2026?

The term is rarely used in current federal drug surveillance. That is not because the mixtures stopped existing. It is because of how drug data is collected and because of how the supply changed.

Crime laboratories and medical examiners report the specific compounds they detect. A toxicology report names fentanyl, carfentanil, or a nitazene. It does not name a street nickname, because nicknames are not chemically meaningful and vary by region and by year. As a result, nicknames like grey death circulate in news coverage for a season and then drop out of the record even when the underlying product is still being sold.

The larger reason is that what made grey death notable in 2017 became ordinary. In 2017, an unlabeled opioid mixture of unknown composition was treated as an emerging threat. Today it describes the illicit opioid supply generally. CDC reported that roughly 70 percent of U.S. overdose deaths in 2023, about 72,000 deaths, involved illegally manufactured fentanyls. The anomaly became the baseline.

So the honest answer is this: grey death as a headline has faded. Grey death as a phenomenon, meaning a grey or off-color powder containing an unknown blend of synthetic opioids at unknown strength, is now the ordinary condition of the street supply, and it is reported under the names of the compounds actually found.

Carfentanil: A Reference

Carfentanil was the component of grey death that alarmed forensic chemists most, and it is the component most relevant to 2026. It is also the component most often described inaccurately, so the details are set out here in full.

Spelling note: the compound is correctly spelled carfentanil. It is frequently written as carfentanyl, by analogy with fentanyl. Both spellings refer to the same substance.

Carfentanil at a Glance

  • Drug class: Synthetic opioid, a fentanyl analog
  • Also spelled: Carfentanyl
  • Legitimate use: A veterinary immobilizing agent developed for very large animals such as elephants. It has no approved human medical use in the United States.
  • Relative potency: Approximately 100 times more potent than fentanyl and approximately 10,000 times more potent than morphine
  • Legal status: Schedule II controlled substance
  • First appeared in U.S. overdose data: 2016, initially in Florida, Michigan, and Ohio
  • Naloxone response: Carfentanil is an opioid and does respond to naloxone. Because of its potency, reversal may require repeated doses and rapid administration.

Why Carfentanil Returned to the Conversation

After the 2016 and 2017 wave, carfentanil detections in U.S. overdose deaths fell off substantially and remained low for several years. That changed. CDC’s December 2024 analysis of State Unintentional Drug Overdose Reporting System data found that overdose deaths with carfentanil detected rose roughly sevenfold, from 29 deaths during January through June 2023 to 238 deaths during the same months of 2024. Detection was reported across 37 states.

Two things about those numbers are worth holding together. In absolute terms, carfentanil remains rare. Against a national total in the tens of thousands, a few hundred deaths is a small fraction. But a sevenfold increase in twelve months, spread across most of the country rather than concentrated in one region, is the signature of a compound entering the supply rather than lingering in it. That is why the CDC flagged it and why carfentanil belongs in any current discussion of what grey death actually was.

What Carfentanil Potency Figures Do and Do Not Mean

The figure most often repeated about carfentanil is that it is 10,000 times more potent than morphine. The figure is accurate, and it is a comparison of how much of each substance is needed to produce a given opioid effect. It is not a statement that carfentanil is 10,000 times more likely to kill on contact, and it is not a measure of how dangerous a specific batch of street drugs is.

Potency matters for a different reason. The more potent a compound is, the smaller the quantity required in a mixture, and the harder it becomes to distribute that quantity evenly. A powder blended by hand in an unregulated setting does not distribute a trace additive uniformly. That is the mechanism behind unpredictable street potency, and it is the reason a compound measured in micrograms creates risk that a compound measured in milligrams does not.

Can You Overdose by Touching or Breathing Near Grey Death or Carfentanil?

This question deserves a direct answer, because early coverage of grey death in 2017, including earlier versions of this page, repeated a claim that medical toxicologists have since addressed directly.

The claim was that simply touching grey death or breathing air near it could be fatal. The American College of Medical Toxicology and the American Academy of Clinical Toxicology, the two professional bodies whose members are physicians specializing in poisoning and overdose, have published and repeatedly updated a position statement on this. Their findings:

  • Fentanyl and its analogs in street formulations are not readily absorbed through intact skin and are not volatile, meaning they do not easily become airborne on their own.
  • Incidental skin contact is unlikely to produce opioid toxicity. For a person to experience opioid effects, the drug has to reach the bloodstream and the brain. Proximity alone does not accomplish that.
  • Nitrile gloves provide sufficient protection for routine handling. An N95 respirator is sufficient in the uncommon situation where drug particles are suspended in the air, such as a pill pressing operation.
  • The toxicologists report no substantiated cases in the medical literature of an emergency responder developing opioid toxicity from incidental contact.

The comparison sometimes offered is a transdermal fentanyl patch, which is engineered specifically to move the drug across skin and still requires hours to reach a therapeutic blood level. Loose powder on a surface has none of that engineering.

This correction is not a minor technical footnote. The professional bodies note that fear of casual exposure has consequences, including hesitation to approach a person who is overdosing. A page like this one that repeats the original claim without updating it contributes to that. The dangers of carfentanil are real and are described above. Overdose by proximity is not among them.

What Replaced Grey Death in the Drug Supply

The compounds that made grey death unpredictable in 2017 have largely been succeeded by others. In a May 2026 public safety advisory, the DEA identified four categories now being found mixed with fentanyl:

  • Xylazine. A veterinary sedative, not an opioid, not approved for human use. It has been associated with prolonged sedation and with severe soft tissue wounds. The DEA has encountered fentanyl mixed with xylazine in nearly every state.
  • Medetomidine. Another veterinary sedative, estimated to be more than 100 times as selective and potent at the alpha-2 receptor as xylazine. In 2024 it displaced xylazine as the most common adulterant in the Philadelphia area supply, and it has been associated with a severe withdrawal syndrome involving high blood pressure, rapid heart rate, and vomiting that has required hospital care.
  • Nitazenes. A family of synthetic opioids developed decades ago and never marketed. Some are more potent than fentanyl. The DEA has reported 22 distinct nitazene compounds since 2020, 21 of which have been placed in Schedule I.
  • Cychlorphine. A newer unregulated synthetic opioid now appearing in the same mixtures.

The practical difference from 2017 is significant. Grey death was an all-opioid mixture, which meant naloxone addressed every active component. Current mixtures are frequently not all opioid. Xylazine and medetomidine are alpha-2 agonists, and naloxone does not reverse them. Public health guidance is that naloxone is still administered in a suspected overdose, because fentanyl is almost always present alongside them, but sedation may persist after the opioid component has been reversed.

Overdose Deaths in Context

Drug overdose deaths in the United States peaked at close to 110,000 in 2022. They have declined for three consecutive years since. CDC provisional data released in May 2026 estimated about 69,973 overdose deaths in 2025, a decline of roughly 14 percent from 2024. Opioid-involved deaths fell from an estimated 55,296 in 2024 to 44,564 in 2025. The decline has not been uniform: most states recorded decreases, while New Mexico, Arizona, and Colorado recorded increases of 10 percent or more.

A fuller breakdown of current federal overdose figures is maintained at GetDetox.com’s drug overdose statistics page.

Dependence, Addiction, and Maintenance Are Three Different Things

Discussion of drugs like grey death tends to collapse several distinct conditions into one word. Separating them is necessary to understand what a person is actually facing.

Physical dependence is a physiological adaptation. When opioids are present continuously, the body adjusts to their presence, and stopping produces withdrawal. Dependence can develop in anyone taking opioids continuously, including patients taking them exactly as prescribed. It is a biological state, not a behavior and not a moral category.

Addiction is different. It develops out of continuous physical and mental dependence over time and involves compulsive use that continues despite harm. Because it involves both the body and the brain, addressing it requires a team of health professionals and time for the body and brain to adapt. No overnight procedure cures it. Programs that promise otherwise are making a claim the biology does not support, and the promise itself is the warning sign, not the price.

Maintenance refers to long-term treatment with an opioid agonist medication. It is a distinct clinical approach with its own considerations, and by design it keeps physical dependence in place rather than resolving it. Whether it fits a given person is a medical question.

Which path fits any individual is determined by that person’s own physician, who knows their medical history, their other conditions, and their circumstances. This page describes these categories. It does not recommend among them.

Frequently Asked Questions

What is grey death made of?

There was never a fixed recipe. Samples analyzed by the Georgia Bureau of Investigation in 2017 contained varying combinations of heroin, illicitly manufactured fentanyl, U-47700, furanyl fentanyl, and in some cases carfentanil. The proportions differed from batch to batch, which is what made the product unpredictable. The grey color was never traced to any single ingredient.

Is carfentanil the same as fentanyl?

No. Carfentanil is a fentanyl analog, meaning it is chemically related, but it is roughly 100 times more potent than fentanyl and roughly 10,000 times more potent than morphine. Carfentanil was developed as a veterinary immobilizing agent for very large animals and has no approved human medical use in the United States. Fentanyl does have approved human medical uses in controlled clinical settings. It is also spelled carfentanyl.

Does naloxone reverse a carfentanil overdose?

Carfentanil is an opioid and does respond to naloxone. Because of its potency, reversal may require repeated doses and prompt administration. The situation is different with xylazine and medetomidine, which are not opioids and are not reversed by naloxone, although naloxone is still given in a suspected overdose because fentanyl is usually present as well.

Can you overdose by touching fentanyl or carfentanil?

According to the position statement of the American College of Medical Toxicology and the American Academy of Clinical Toxicology, incidental skin contact is unlikely to cause opioid toxicity. Street formulations of fentanyl and its analogs are not readily absorbed through intact skin and are not volatile. The organizations report no substantiated cases in the medical literature of a responder developing opioid toxicity from incidental contact. Nitrile gloves are described as sufficient for routine handling.

Why is grey death not in the news anymore?

Forensic laboratories and medical examiners report the specific compounds detected rather than regional street nicknames, so nicknames tend to disappear from official data. More importantly, unlabeled opioid mixtures of unknown potency stopped being unusual. CDC estimated that about 70 percent of U.S. overdose deaths in 2023 involved illegally manufactured fentanyls. What was an emerging threat in 2017 is now the general condition of the supply.

What is in the drug supply now instead?

A DEA public safety advisory issued in May 2026 identified xylazine, medetomidine, nitazenes, and cychlorphine as substances being mixed with fentanyl. Xylazine and medetomidine are veterinary sedatives not approved for human use. Nitazenes and cychlorphine are unregulated synthetic opioids, some more potent than fentanyl. None of them can be identified by the person taking the drug.

Where can someone get help with opioid dependence?

The SAMHSA National Helpline is free, confidential, and available 24 hours a day at 1-800-662-4357. It provides treatment referral and information services in English and Spanish. A person’s own physician is the appropriate source for guidance on which medical approach fits their individual history and circumstances.

Related Reading

Sources

  1. Tanz LJ, Stewart A, Gladden RM, Ko JY, Owens L, O’Donnell J. Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths, United States, 2021 to 2024. MMWR Morb Mortal Wkly Rep. December 5, 2024. cdc.gov
  2. U.S. Drug Enforcement Administration. Public Safety Advisory: Heightened Threat from Fentanyl Mixed with Emerging Synthetic Drugs. May 12, 2026. dea.gov
  3. American College of Medical Toxicology and American Academy of Clinical Toxicology. Position Statement: Preventing Occupational Opioid Exposure to Emergency Responders. acmt.net
  4. National Center for Health Statistics, CDC. U.S. Overdose Deaths Decrease for Third Consecutive Year in 2025. May 13, 2026. cdc.gov
  5. O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700, 10 States, July to December 2016. MMWR Morb Mortal Wkly Rep. 2017. cdc.gov
  6. National Institute on Drug Abuse. Fentanyl DrugFacts. nida.nih.gov
  7. Substance Abuse and Mental Health Services Administration. National Helpline. samhsa.gov

Educational resource. The Waismann Method operated from 1998 until it closed in 2025. This site is an educational archive. No treatment is offered or arranged here. The information on this page is not a substitute for professional medical advice and does not describe any individual’s medical situation. Anyone with questions about opioid dependence should consult their own physician. For free, confidential treatment referral, the SAMHSA National Helpline is available 24 hours a day at 1-800-662-4357.

Reviewed by Clare Waismann, SUDCC II. Published by Waismann Method®, Opioid Dependence Experts.

More To Explore